2-Methyl-2H-indazole-5-carbonitrile | 1159511-49-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡唑类
• 英文名称: 2-Methyl-2H-indazole-5-carbonitrile
• 英文别名: 2-methylindazole-5-carbonitrile
• CAS: 1159511-49-5
• 化学式: C₉H₇N₃
• mdl: MFCD12028583
• 分子量: 157.17
• InChiKey: HJOFLALMDZWZME-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.111
• 拓扑面积：
  41.6
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• [EN] ANTIVIRAL AGENTS AND USES THEREOF<br/>[FR] AGENTS ANTIVIRAUX ET LEURS UTILISATIONS
  申请人：UNIV GRIFFITH

  公开号：WO2021016670A1

  公开（公告）日：2021-02-04

  The present invention relates to a compound of formula (I), or a pharmaceutically acceptable salt thereof: Formula (I) In which R3 is selected from the group consisting of optionally substituted N-linked naphthotriazole, optionally substituted N-linked indazole, and certain N-linked triazoles. The present invention also relates to uses of the compounds in treating a disease, disorder or condition caused by viral infection, and pharmaceutical compositions comprising the compounds.

  本发明涉及一种化合物，其化学式为(I)，或其药学上可接受的盐：化学式(I) 其中R3选自可选择的取代N-连接的萘三唑、可选择的取代N-连接的吲唑和某些N-连接的三唑组成的群。本发明还涉及将该化合物用于治疗由病毒感染引起的疾病、疾病或病况的用途，以及包含该化合物的药物组合物。
• [EN] PYRAZOLE- AND INDAZOLE-SUBSTITUTED OXADIAZOLOPYRIDINE DERIVATIVES FOR USE AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS<br/>[FR] DÉRIVÉS D'OXADIAZOLOPYRIDINE À SUBSTITUTION PYRAZOLE ET INDAZOLE DESTINÉS À ÊTRE UTILISÉS EN TANT QU'INHIBITEURS DE LA GHRÉLINE O-ACYL TRANSFÉRASE (GOAT)
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2019149658A1

  公开（公告）日：2019-08-08

  The present invention relates to compounds of general formula I, wherein the groups R1 and R2 are defined as in claim 1, which have valuable pharmacological properties, in particular bind to ghrelin O-acyl transferase (GOAT) and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular obesity.

  本发明涉及通式I的化合物，其中基团R1和R2的定义如权利要求书中所述，具有有价值的药理特性，特别是与ghrelin O-acyl转移酶（GOAT）结合并调节其活性。这些化合物适用于治疗和预防受该受体影响的疾病，如代谢性疾病，特别是肥胖症。
• Pyrazole- and indazole-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors
  申请人：Boehringer Ingelheim International GmbH

  公开号：US11136337B2

  公开（公告）日：2021-10-05

  The present invention relates to compounds of general formula I, wherein the groups R1 and R2 are defined as in claim 1, which have valuable pharmacological properties, in particular bind to ghrelin O-acyl transferase (GOAT) and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular obesity.

  本发明涉及通式 I 的化合物，其中基团 R1 和 R2 的定义如权利要求 1 所述，这些化合物 具有重要的药理特性，特别是能与胃泌素 O-酰基转移酶（GOAT）结合并调节其活性。这些化合物适用于治疗和预防受该受体影响的疾病，如代谢性疾病，特别是肥胖症。
• PYRAZOLE- AND INDAZOLE- SUBSTITUTED OXADIAZOLOPYRIDINE DERIVATIVES FOR USE AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS
  申请人：Boehringer Ingelheim International GmbH

  公开号：US20210040113A1

  公开（公告）日：2021-02-11

  The present invention relates to compounds of general formula I, wherein the groups R 1 and R 2 are defined as in claim 1 , which have valuable pharmacological properties, in particular bind to ghrelin O-acyl transferase (GOAT) and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular obesity.